Research graph
References from The probability of Plasmodium vivax acute illness following primary infection and relapse in Papua New Guinea. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2024 · External reference
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study
10.1016/s0140-6736(19)31096-7 · 2019 · External reference
Global economic costs due to vivax malaria and the potential impact of its radical cure: a modelling study
10.1371/journal.pmed.1003614 · 2021 · External reference
Plasmodium vivax in the era of the shrinking P. falciparum map
10.1016/j.pt.2020.03.009 · 2020 · External reference
Global epidemiology of Plasmodium vivax
10.4269/ajtmh.16-0141 · 2016 · External reference
A systematic review of sub-microscopic Plasmodium vivax infection
10.1186/s12936-015-0884-z · 2015 · External reference
Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study
10.1016/s1473-3099(18)30411-0 · 2018 · External reference
Infectivity of symptomatic and asymptomatic Plasmodium vivax infections to a Southeast Asian vector, Anopheles dirus
10.1016/j.ijpara.2016.10.006 · 2017 · External reference
The relative contribution of symptomatic and asymptomatic Plasmodium vivax and Plasmodium falciparum infections to the infectious reservoir in a low-endemic setting in Ethiopia
10.1093/cid/cix1123 · 2018 · External reference
Plasmodium gametocytes in field studies: do we measure commitment to transmission or detectability?
10.1016/j.pt.2018.02.009 · 2018 · External reference
The neglected burden of Plasmodium vivax malaria
10.4269/ajtmh.2001.64.97 · 2001 · External reference
Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets
10.1016/b978-0-12-407826-0.00003-5 · 2013 · External reference
A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings
10.1371/journal.pntd.0002882 · 2014 · External reference
Genomic analyses reveal the common occurrence and complexity of Plasmodium vivax relapses in Cambodia
10.1128/mbio.01888-17 · 2018 · External reference
A retrospective examination of reinfection of humans with Plasmodium vivax
10.4269/ajtmh.2004.70.642 · 2004 · External reference
Plasmodium vivax blood-stage dynamics
10.1645/0022-3395(2002)088[0521:pvbsd]2.0.co;2 · 2002 · External reference
Malariotherapy- insanity at the service of malariology
10.1016/b978-0-12-407826-0.00006-0 · 2013 · External reference
Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age
10.1093/infdis/jis580 · 2012 · External reference
Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model
10.1371/journal.pmed.1001891 · 2015 · External reference
The global burden of Plasmodium vivax malaria is obscure and insidious
10.1371/journal.pmed.1003799 · 2021 · External reference
Estimating the hidden magnitude of the malaria community burden
10.1016/s1473-3099(20)30142-0 · 2020 · External reference
Association between the proportion of Plasmodium falciparum and Plasmodium vivax infections detected by passive surveillance and the magnitude of the asymptomatic reservoir in the community: a pooled analysis of paired health facility and community data
10.1016/s1473-3099(20)30059-1 · 2020 · External reference
Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children
2010 · External reference
Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection
10.1186/1475-2875-8-158 · 2009 · External reference
Defining the relationship between Plasmodium vivax parasite rate and clinical disease
10.1186/s12936-015-0706-3 · 2015 · External reference
Relative contribution of low-density and asymptomatic infections to Plasmodium vivax transmission in the Amazon: pooled analysis of individual participant data from population-based cross-sectional surveys
2022 · External reference
Modelling the epidemiology of residual Plasmodium vivax malaria in a heterogeneous host population: a case study in the Amazon Basin
10.1371/journal.pcbi.1007377 · 2020 · External reference
Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses
10.1186/s12936-018-2318-1 · 2018 · External reference
Resolving the cause of recurrent Plasmodium vivax malaria probabilistically
10.1038/s41467-019-13412-x · 2019 · External reference
Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: an analysis of the SPf66 vaccine trial
10.1073/pnas.2401024121 · 2024 · External reference
The incidence and differential seasonal patterns of Plasmodium vivax primary infections and relapses in a cohort of children in Papua New Guinea
10.1371/journal.pntd.0004582 · 2016 · External reference
How much remains undetected? Probability of molecular detection of human Plasmodia in the field
10.1371/journal.pone.0019010 · 2011 · External reference
Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea
10.1371/journal.pntd.0001424 · 2011 · External reference
A high force of Plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in Papua New Guinean children
10.1371/journal.pntd.0002403 · 2013 · External reference
Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children
10.1073/pnas.1200841109 · 2012 · External reference
Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping
10.1186/1475-2875-8-250 · 2009 · External reference
Theoretical origin of genetically homologous Plasmodium vivax malarial recurrences
2022 · External reference
Hidden biomass of intact malaria parasites in the human spleen
10.1056/nejmc2023884 · 2021 · External reference
Hypnozoite depletion in successive Plasmodium vivax relapses
10.1371/journal.pntd.0010648 · 2022 · External reference
Unresolved reference
External reference
Estimation of heterogeneity in malaria transmission by stochastic modelling of apparent deviations from mass action kinetics
10.1186/1475-2875-7-12 · 2008 · External reference
Ensemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccine
10.1371/journal.pmed.1001157 · 2012 · External reference
Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax
1950 · External reference
Unresolved reference
External reference
Simplified calculation of body-surface area
10.1056/nejm198710223171717 · 1987 · External reference
Unresolved reference
External reference
Unresolved reference
2022 · External reference
Unresolved reference
External reference
Quantifying effect of geographic location on epidemiology of Plasmodium vivax malaria
10.3201/eid1907.121674 · 2013 · External reference
Re-assessing the relationship between sporozoite dose and incubation period in Plasmodium vivax malaria: a systematic re-analysis
10.1017/s0031182013002369 · 2014 · External reference
Plasmodium vivax controlled human malaria infection - progress and prospects
10.1016/j.pt.2016.11.001 · 2017 · External reference
A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas
10.4269/ajtmh.2006.75.19 · 2006 · External reference
Variation in natural exposure to anopheles mosquitoes and its effects on malaria transmission
10.7554/elife.32625 · 2018 · External reference
Geographical variation in Plasmodium vivax relapse
10.1186/1475-2875-13-144 · 2014 · External reference
The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity
10.1080/00034983.1995.11812966 · 1995 · External reference
Repeated mosquito net distributions, improved treatment, and trends in malaria cases in sentinel health facilities in Papua New Guinea
10.1186/s12936-019-2993-6 · 2019 · External reference
The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu
10.1016/s0035-9203(96)90406-x · 1996 · External reference
The risk of malarial infections and disease in Papua New Guinean children
10.4269/ajtmh.2007.76.997 · 2007 · External reference
The complex relationship of exposure to new Plasmodium infections and incidence of clinical malaria in Papua New Guinea
10.7554/elife.23708 · 2017 · External reference
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial
10.1371/journal.pmed.1001195 · 2012 · External reference
The effect of distance from home on attendance at a small rural health centre in Papua New Guinea
10.1093/ije/27.5.878 · 1998 · External reference
Population-level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre, East Shoa Zone, Oromia, Ethiopia
10.1186/s12936-017-1944-3 · 2017 · External reference
The relative impact of interventions on sympatric Plasmodium vivax and Plasmodium falciparum malaria: a systematic review
10.1371/journal.pntd.0010541 · 2022 · External reference
Associations of peak shifts in age--prevalence for human malarias with bednet coverage
10.1016/s0035-9203(01)90314-1 · 2001 · External reference
High proportions of asymptomatic and submicroscopic Plasmodium vivax infections in a peri-urban area of low transmission in the Brazilian Amazon
10.1186/s13071-018-2787-7 · 2018 · External reference
Priority setting in HIV, tuberculosis, and malaria - new cost-effectiveness results from WHO-CHOICE
2021 · External reference
A multiscale mathematical model of Plasmodium vivax transmission
10.1007/s11538-022-01036-0 · 2022 · External reference
Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission
10.7554/elife.04692 · 2014 · External reference
Mathematical modelling of the impact of expanding levels of malaria control interventions on Plasmodium vivax
10.1038/s41467-018-05860-8 · 2018 · External reference
Risk analysis of the re-emergence of Plasmodium vivax malaria in Japan using a stochastic transmission model
10.1007/s12199-010-0184-8 · 2011 · External reference
Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency
10.1016/j.jtbi.2012.08.024 · 2013 · External reference
A mathematical model for Plasmodium vivax malaria transmission: estimation of the impact of transmission-blocking immunity in an endemic area
1991 · External reference
A mathematical model for the transmission of Plasmodium vivax malaria
10.1016/s1383-5769(02)00084-3 · 2003 · External reference
Basic reproduction number for the transmission of Plasmodium vivax malaria
2001 · External reference
The dilution effect of the domestic animal population on the transmission of P. vivax malaria
10.1016/j.jtbi.2010.06.032 · 2010 · External reference
A quantitative risk assessment approach for mosquito-borne diseases: malaria re-emergence in southern France
10.1186/1475-2875-7-147 · 2008 · External reference
Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria
2016 · External reference
An activation-clearance model for Plasmodium vivax malaria
10.1007/s11538-020-00706-1 · 2020 · External reference
A mathematical model of transmission of Plasmodium vivax malaria with a constant time delay from infection to infectious
2003 · External reference
Optimal interruption of P. vivax malaria transmission using mass drug administration
10.1007/s11538-023-01153-4 · 2023 · External reference
Population heterogeneity in Plasmodium vivax relapse risk
10.1371/journal.pntd.0010990 · 2022 · External reference
Antibody dynamics for Plasmodium vivax malaria: a mathematical model
10.1007/s11538-020-00837-5 · 2021 · External reference
Hypnozoite dynamics for Plasmodium vivax malaria: the epidemiological effects of radical cure
2021 · External reference
Investigation of P. vivax elimination via mass drug administration: a simulation study
10.1016/j.epidem.2024.100789 · 2024 · External reference
Mathematical model for the transmission of Plasmodium vivax malaria
2007 · External reference
Stability of a mathematical model of malaria transmission with relapse
2014 · External reference
A superinfection model on malaria transmission: analysis on the invasion basic reproductive number
2021 · External reference
Recurrent malaria dynamics: insight from mathematical modelling
10.1140/epjp/s13360-022-02510-3 · 2022 · External reference
Optimal control analysis of a mathematical model for recurrent malaria dynamics
10.1007/s43069-023-00197-5 · 2023 · External reference
Efficiency and economic analysis of intervention strategies for recurrent malaria transmission
10.1007/s11135-023-01664-1 · 2023 · External reference
Dynamics system in the SEIR-SI model of the spread of malaria with recurrence
10.34312/jjbm.v4i1.18754 · 2023 · External reference
The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China
10.1186/s12916-021-02214-y · 2022 · External reference
A spatial multiscale mathematical model of Plasmodium vivax transmission
10.1007/s00285-024-02166-w · 2024 · External reference
Developing an agent-based model for simulating the dynamic spread of Plasmodium vivax malaria: a case study of Sarbaz, Iran
2019 · External reference
Does mass chloroquine treatment have any role in the elimination of Plasmodium vivax?
10.1186/s12936-025-05399-2 · 2025 · External reference
Intervention portfolios analysis of Plasmodium vivax control in central China
10.1186/s12936-024-05063-1 · 2024 · External reference
A validated agent-based model to study the spatial and temporal heterogeneities of malaria incidence in the rainforest environment
10.1186/s12936-015-1030-7 · 2015 · External reference
Mathematical modelling of the dynamics of infectious disease with relapse
2020 · External reference
Mathematical analysis of reinfection and relapse in malaria dynamics
10.1016/j.amc.2020.125044 · 2020 · External reference
Modelling malaria transmission in a population with SEIRS method
10.1063/5.0023508 · 2020 · External reference
Modeling and investigating malaria P. Falciparum and P. Vivax infections: application to djibouti data
2024 · External reference
Modeling of re-emerging Plasmodium vivax in the north area of the Republic of Korea based on a mathematical model
2006 · External reference
Modelling the impact of rapid diagnostic tests on Plasmodium vivax malaria in South Korea: a cost-benefit analysis
2021 · External reference
A mathematical model for assessing the effectiveness of controlling relapse in Plasmodium vivax malaria endemic in the Republic of Korea
2020 · External reference
Malaria elimination on Hainan Island despite climate change
10.1038/s43856-022-00073-z · 2022 · External reference
Development of a Plasmodium vivax malaria model for evaluating the effects of control strategies on the malaria burden in Democratic People’s Republic of Korea
10.3389/fpubh.2024.1423004 · 2024 · External reference
Cost-benefit analysis of tafenoquine for radical cure of Plasmodium vivax malaria in Korea
2022 · External reference
Evaluating the impact of the Malakit intervention on malaria transmission in the Guiana Shield: a mathematical modelling study
2025 · External reference
The potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW India
2013 · External reference
Heterogeneous mosquito exposure increases Plasmodium vivax and Plasmodium falciparum co-infections: a modelling study
2024 · External reference
Potential role of vaccines in elimination of Plasmodium vivax
10.1016/j.parint.2022.102592 · 2022 · External reference
Assessing the impact of relapse, reinfection and recrudescence on malaria eradication policy: a bifurcation and optimal control analysis
10.3390/tropicalmed7100263 · 2022 · External reference
Using observed incidence to calibrate the transmission level of a mathematical model for Plasmodium vivax dynamics including case management and importation
10.1016/j.mbs.2021.108750 · 2022 · External reference
Early transmission of sensitive strain slows down emergence of drug resistance in Plasmodium vivax
2020 · External reference
Quantifying the impact of interventions against Plasmodium vivax: a model for country-specific use
10.1016/j.epidem.2024.100747 · 2024 · External reference
Plasmodium vivax readiness to transmit: implication for malaria eradication
10.1186/s12918-018-0669-4 · 2019 · External reference
Individual variation in Plasmodium vivax malaria risk: are repeatedly infected people just unlucky?
10.1371/journal.pntd.0011020 · 2023 · External reference
A simulation model of the within-host dynamics of Plasmodium vivax infection
10.1186/s12936-015-0580-z · 2015 · External reference
Modeling the effects of relapse in the transmission dynamics of malaria parasites
10.1155/2012/921715 · 2012 · External reference
A model for malaria treatment evaluation in the presence of multiple species
10.1016/j.epidem.2023.100687 · 2023 · External reference
Malaria elimination transmission and costing in the Asia-Pacific: a multi-species dynamic transmission model
10.12688/wellcomeopenres.14771.2 · 2019 · External reference
Developing sero-diagnostic tests to facilitate Plasmodium vivax serological test-and-treat approaches: modeling the balance between public health impact and overtreatment
10.1186/s12916-022-02285-5 · 2022 · External reference
Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: a modelling study
10.1371/journal.pmed.1003535 · 2021 · External reference
Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil
2023 · External reference
Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: a cost-effectiveness analysis using a transmission model
10.1371/journal.pmed.1004255 · 2024 · External reference
Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics
10.1016/s1473-3099(24)00689-3 · 2025 · External reference
How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites
10.1186/s12936-021-04017-1 · 2021 · External reference
A hybrid transmission model for Plasmodium vivax accounting for superinfection, immunity and the hypnozoite reservoir
10.1007/s00285-024-02088-7 · 2024 · External reference
A systematic analysis of the human immune response to Plasmodium vivax
2023 · External reference
The pathophysiology of vivax malaria
10.1016/j.pt.2009.02.003 · 2009 · External reference
Relapse
10.1016/b978-0-12-397900-1.00002-5 · 2012 · External reference
Plasmodium vivax sporozoite challenge in malaria-naïve and semi-immune Colombian volunteers
10.1371/journal.pone.0099754 · 2014 · External reference
